Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - to be updated in light of the findings.

ZURICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their expertise ...

A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...